Bank Of New York Mellon Corp Harpoon Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $87,700 - $247,335	-49,270 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$3.54 - $8.08 $1,221 - $2,787	345 Added 0.71%	49,270 $245,000
Q4 2021 Feb 11, 2022	BUY	$5.69 - $7.83 $5,934 - $8,166	1,043 Added 2.18%	48,925 $369,000
Q3 2021 Nov 12, 2021	BUY	$7.88 - $14.0 $11,764 - $20,902	1,493 Added 3.22%	47,882 $378,000
Q2 2021 Aug 11, 2021	BUY	$13.81 - $23.25 $79,573 - $133,966	5,762 Added 14.18%	46,389 $643,000
Q1 2021 May 13, 2021	BUY	$17.65 - $24.16 $104,735 - $143,365	5,934 Added 17.1%	40,627 $849,000
Q4 2020 Feb 09, 2021	BUY	$12.83 - $17.84 $47,676 - $66,293	3,716 Added 12.0%	34,693 $576,000
Q3 2020 Nov 12, 2020	SELL	$11.01 - $18.52 $1,948 - $3,278	-177 Reduced 0.57%	30,977 $526,000
Q2 2020 Aug 12, 2020	BUY	$11.11 - $24.72 $87,913 - $195,609	7,913 Added 34.05%	31,154 $517,000
Q1 2020 May 06, 2020	BUY	$10.74 - $16.32 $1,084 - $1,648	101 Added 0.44%	23,241 $269,000
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $56,677 - $90,140	4,380 Added 23.35%	23,140 $342,000
Q3 2019 Nov 07, 2019	BUY	$10.93 - $17.47 $205,046 - $327,737	18,760 New	18,760 $256,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.